Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Influenza

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 121 articles:
HTML format
Text format



Single Articles


    April 2017
  1. HUANG X, Mengersen K, Milinovich G, Hu W, et al
    Effect of weather variability on seasonal influenza among different age groups in Queensland, Australia: A Bayesian spatiotemporal analysis.
    J Infect Dis. 2017 Apr 12. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2017
  2. MOHN KG, Zhou F, Brokstad KA, Sridhar S, et al
    Live attenuated influenza vaccination boosts durable cross-reactive and protection-associated T-cells in children.
    J Infect Dis. 2017 Mar 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. SHAY DK, Chillarige Y, Kelman J, Forshee RA, et al
    Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012-2013 and 2013-2014.
    J Infect Dis. 2017 Mar 2. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. MONTO AS
    Moving Toward Improved Influenza Vaccines.
    J Infect Dis. 2017 Mar 2. doi: 10.1093.
    PubMed     Text format    


    February 2017
  5. LIU L, Nachbagauer R, Zhu L, Huang Y, et al
    Induction of Broadly Cross-Reactive Stalk-Specific Antibody Responses to Influenza Group 1 and Group 2 Hemagglutinins by Natural H7N9 Virus Infection in Humans.
    J Infect Dis. 2017;215:518-528.
    PubMed     Text format     Abstract available


  6. SKOWRONSKI DM, Chambers C, De Serres G, Sabaiduc S, et al
    Serial vaccination and the antigenic distance hypothesis: effects on influenza vaccine effectiveness during A(H3N2) epidemics in Canada, 2010-11 to 2014-15.
    J Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed     Text format    


  7. PETRIE JG, Monto AS
    Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed     Text format    


  8. MARTINEZ-BAZ I, Casado I, Navascues A, Diaz-Gonzalez J, et al
    Effect of Repeated Vaccination With the Same Vaccine Component Against Influenza A(H1N1)pdm09.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed     Text format    


    January 2017
  9. ARNOTT A, Carville K, Franklin L, Sullivan SG, et al
    Consecutive Influenza Infections in Both Adults and Children.
    J Infect Dis. 2017 Jan 18. doi: 10.1093.
    PubMed     Text format    


    December 2016
  10. EWING A, Lee EC, Viboud C, Bansal S, et al
    Contact, travel, and transmission: The impact of winter holidays on influenza dynamics in the United States.
    J Infect Dis. 2016 Dec 28. pii: jiw642. doi: 10.1093.
    PubMed     Text format     Abstract available


  11. HADLER JL
    Christmas-New Year influenza lull: not too late for vaccination.
    J Infect Dis. 2016 Dec 28. pii: jiw643. doi: 10.1093.
    PubMed     Text format    


  12. JEGASKANDA S, Co MD, Cruz J, Subbarao K, et al
    Human seasonal influenza A viruses induce H7N9-cross-reactive antibody-dependent cellular cytotoxicity (ADCC) antibodies that are directed towards the nucleoprotein.
    J Infect Dis. 2016 Dec 23. pii: jiw629. doi: 10.1093.
    PubMed     Text format     Abstract available


  13. TRIEU MC, Zhou F, Lartey S, Jul-Larsen A, et al
    Long-term maintenance of the influenza-specific cross-reactive memory CD4+ T-cell responses following repeated annual influenza vaccination.
    J Infect Dis. 2016 Dec 22. pii: jiw619. doi: 10.1093.
    PubMed     Text format     Abstract available


  14. PETRIE JG, Parkhouse K, Ohmit SE, Malosh RE, et al
    Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains.
    J Infect Dis. 2016;214:1947-1951.
    PubMed     Text format     Abstract available


  15. SHIMIZU K, Wulandari L, Poetranto ED, Setyoningrum RA, et al
    Seroevidence for a High Prevalence of Subclinical Infection With Avian Influenza A(H5N1) Virus Among Workers in a Live-Poultry Market in Indonesia.
    J Infect Dis. 2016;214:1929-1936.
    PubMed     Text format     Abstract available


  16. FEDSON DS
    Statins, Influenza Vaccination and Influenza.
    J Infect Dis. 2016.
    PubMed     Text format    


  17. FEDSON DS
    Statins, Influenza Vaccination and Influenza.
    J Infect Dis. 2016 Dec 7. doi: 10.1093.
    PubMed     Text format    


    October 2016
  18. LIU WJ, Tan S, Zhao M, Quan C, et al
    Cross-Immunities against Avian Influenza H7N9 Virus in the Healthy Population Affected by Antigenicity-Dependent Substitutions.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  19. MORI I
    Vaccination Effectively Prevents Central Nervous System Invasion by Influenza A(H5N1) Virus Through the Olfactory Pathway: A Proposed Mechanism of Neuroprotection.
    J Infect Dis. 2016.
    PubMed     Text format    



  20. Live attenuated influenza vaccine in children induces B-cell responses in tonsils.
    J Infect Dis. 2016.
    PubMed     Text format    


    September 2016
  21. LE GARS M, Kay AW, Bayless NL, Aziz N, et al
    Increased Pro-Inflammatory Responses of Monocytes and Plasmacytoid Dendritic Cells to Influenza A Virus Infection During Pregnancy.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  22. MADAN A, Segall N, Ferguson M, Frenette L, et al
    Immunogenicity and safety of an AS03-adjuvanted H7N9 pandemic influenza vaccine in a randomized trial in healthy adults.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  23. ETTENSOHN DB, Frampton MW, Nichols JE, Roberts NJ Jr, et al
    HUMAN ALVEOLAR MACROPHAGES MAY NOT BE SUSCEPTIBLE TO DIRECT INFECTION BY A HUMAN INFLUENZA VIRUS.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    August 2016
  24. REBER AJ, Kim JH, Coleman LA, Spencer SM, et al
    Seasonal Influenza Vaccination of Children Induces Humoral and Cell-Mediated Immunity Beyond the Current Season: Cross-reactivity with Past and Future Strains.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  25. EDWARDS KM, Keitel WA
    Challenges Remain for Influenza Vaccination of Children.
    J Infect Dis. 2016.
    PubMed     Text format    


  26. KIM JH, Mishina M, Chung JR, Cole KS, et al
    Cell-mediated immunity against antigenically drifted influenza A(H3N2) viruses in children during a vaccine mismatch season.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  27. VALKENBURG SA, Zhang Y, Chan KY, Leung K, et al
    Pre-existing ADCC antibody responses are stable longitudinally and cross-reactive responses are not boosted by recent influenza exposure.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    July 2016
  28. MCLEAN HQ, Chow BD, VanWormer JJ, King JP, et al
    The Effect of Statin Use on Influenza Vaccine Effectiveness.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    June 2016
  29. JEGASKANDA S, Luke C, Hickman HD, Sangster MY, et al
    The generation and protective ability of influenza-specific antibody-dependent cellular cytotoxicity in humans elicited by vaccination, natural infection or experimental challenge.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    May 2016
  30. MOHN KG, Brokstad KA, Pathirana RD, Bredholt G, et al
    Live attenuated influenza vaccination in children induces B-cell responses in tonsils.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  31. SCHOTSAERT M, Garcia-Sastre A
    A high resolution look at influenza antigenic drift.
    J Infect Dis. 2016.
    PubMed     Text format    


  32. FLANNERY B, Zimmerman RK, Gubareva LV, Garten RJ, et al
    Enhanced genetic characterization of influenza A(H3N2) viruses and vaccine effectiveness by genetic group, 2014-2015.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    April 2016
  33. MOST J, Weiss G
    Consecutive Infections With Influenza A and B Virus in Children During the 2014-2015 Seasonal Influenza Epidemic.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  34. NEUZIL KM
    The Art and Science of Delivering Influenza Vaccines.
    J Infect Dis. 2016.
    PubMed     Text format    


  35. PETRIE JG, Ohmit SE, Truscon R, Johnson E, et al
    Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007-2008 Influenza Season.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    March 2016
  36. TCHERNIUK S, Cenac N, Comte M, Frouard J, et al
    Formyl peptide receptor 2 plays a deleterious role during influenza A virus infections.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  37. CRABTREE JN, He W, Guan W, Flage M, et al
    Autoimmune variant PTPN22 C1858T is associated with impaired responses to influenza virus vaccination.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  38. SKJERVEN HO, Megremis S, Papadopoulos NG, Mowinckel P, et al
    Virus Type and Genomic Load in Acute Bronchiolitis: Severity and Treatment Response With Inhaled Adrenaline.
    J Infect Dis. 2016;213:915-21.
    PubMed     Text format     Abstract available


  39. VIBOUD C, Simonsen L, Fuentes R, Flores J, et al
    Global Mortality Impact of the 1957-1959 Influenza Pandemic.
    J Infect Dis. 2016;213:738-45.
    PubMed     Text format     Abstract available


    February 2016
  40. SELF WH, Williams DJ, Zhu Y, Ampofo K, et al
    Respiratory Viral Detection in Children and Adults: Comparing Asymptomatic Controls and Patients With Community-Acquired Pneumonia.
    J Infect Dis. 2016;213:584-91.
    PubMed     Text format     Abstract available


  41. ZURLI V, Gallotta M, Taccone M, Chiarot E, et al
    Positive contribution of adjuvanted influenza vaccines on the resolution of bacterial superinfections.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  42. MASCITELLI L, Goldstein MR
    How regulatory T cells induction by statin drugs may impair influenza vaccine immunogenicity and effectiveness.
    J Infect Dis. 2016.
    PubMed     Text format    


  43. OBOHO I, Reed C, Gargiullo P, Leon M, et al
    The benefit of early influenza antiviral treatment of pregnant women hospitalized with laboratory-confirmed influenza.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  44. TITA AT, Andrews WW
    Influenza Vaccination and Antiviral Therapy in Pregnant Women.
    J Infect Dis. 2016.
    PubMed     Text format    


    January 2016
  45. PENNINGTON SH, Thompson AL, Wright AK, Ferreira DM, et al
    Oral typhoid vaccination with Ty21a generates Ty21a-responsive and heterologous influenza-responsive CD4+ and CD8+ T-cells at the human intestinal mucosa.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  46. PAVIA AT
    Influenza Vaccine Effectiveness: Mysteries, Enigmas, and a Few Clues.
    J Infect Dis. 2016.
    PubMed     Text format    


  47. GAGLANI M, Pruszynski J, Murthy K, Clipper L, et al
    Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    December 2015
  48. SOBHANIE M, Matsuoka Y, Jegaskanda S, Fitzgerald T, et al
    Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9).
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  49. L'HUILLIER AG, Abed Y, Petty TJ, Cordey S, et al
    E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant Recipient.
    J Infect Dis. 2015;212:1726-34.
    PubMed     Text format     Abstract available


  50. BAGGA B, Cehelsky JE, Vaishnaw A, Wilkinson T, et al
    Effect of Preexisting Serum and Mucosal Antibody on Experimental Respiratory Syncytial Virus (RSV) Challenge and Infection of Adults.
    J Infect Dis. 2015;212:1719-25.
    PubMed     Text format     Abstract available


  51. MUNYWOKI PK, Koech DC, Agoti CN, Bett A, et al
    Frequent Asymptomatic Respiratory Syncytial Virus Infections During an Epidemic in a Rural Kenyan Household Cohort.
    J Infect Dis. 2015;212:1711-8.
    PubMed     Text format     Abstract available


    November 2015
  52. SCHULERT GS, Zhang M, Fall N, Husami A, et al
    Whole exome sequencing reveals mutations in hemophagocytic lymphohistiocytosis and macrophage activation syndrome linked genes in fatal cases of H1N1 influenza.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  53. OHMIT SE, Petrie JG, Malosh RE, Johnson E, et al
    Substantial Influenza Vaccine Effectiveness Observed in Households with Children in a Season in which A (pH1N1) Predominated (2013-2014).
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  54. ARRIOLA CS, Chaves SS
    Reply to Chughtai et al.
    J Infect Dis. 2015;212:1684-5.
    PubMed     Text format    


  55. CHUGHTAI AA, Rahman B, MacIntyre CR
    Commentary On Arriola et al. Antivirals and Effect Modification in Influenza Studies.
    J Infect Dis. 2015;212:1683-4.
    PubMed     Text format    


    October 2015
  56. BLACK S, Nicolay U, Del Giudice G, Rappuoli R, et al
    Influence of Statins on Influenza Vaccine Response in Elderly Individuals.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  57. OMER SB, Phadke VK, Bednarczyk RA, Chamberlain AT, et al
    Impact of Statins on Influenza Vaccine Effectiveness Against Medically Attended Acute Respiratory Illness.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  58. ATMAR RL, Keitel WA
    Influenza Vaccination of Patients Receiving Statins: Where Do We Go From Here?
    J Infect Dis. 2015.
    PubMed     Text format    


  59. LEE N, Chan MC, Lui GC, Li R, et al
    High Viral Load and Respiratory Failure in Adults Hospitalized for Respiratory Syncytial Virus Infections.
    J Infect Dis. 2015;212:1237-40.
    PubMed     Text format     Abstract available


    September 2015
  60. DAVEY RT JR, Markowitz N, Beigel J, Wentworth D, et al
    INSIGHT FLU005: An Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  61. GESSNER BD
    Severe Acute Respiratory Illness in Sub-Saharan Africa.
    J Infect Dis. 2015;212:843-4.
    PubMed     Text format    


    August 2015
  62. GLENN GM, Fries LF, Thomas DN, Smith G, et al
    A randomized, blinded, controlled, dose-ranging study of a respiratory syncytial virus recombinant fusion (F) nanoparticle vaccine in healthy women of childbearing age.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  63. NELSON MI, Wentworth DE, Das SR, Sreevatsan S, et al
    Evolutionary dynamics of influenza A viruses in US exhibition swine.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  64. BARANOVICH T, Bahl J
    Influenza A Virus diversity and transmission in exhibition swine.
    J Infect Dis. 2015.
    PubMed     Text format    


  65. WANG W, Facundo EA, Chen Q, Anderson CM, et al
    Sera from middle-aged adults vaccinated annually with seasonal influenza vaccines cross-neutralize some potential pandemic influenza viruses.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    July 2015
  66. SUAREZ NM, Bunsow E, Falsey AR, Walsh EE, et al
    Superiority of transcriptional profiling over procalcitonin for distinguishing bacterial from viral lower respiratory tract infections in hospitalized adults.
    J Infect Dis. 2015;212:213-22.
    PubMed     Text format     Abstract available


  67. TSALIK EL, McClain M, Zaas AK
    Moving toward prime time: host signatures for diagnosis of respiratory infections.
    J Infect Dis. 2015;212:173-5.
    PubMed     Text format    


  68. PLOTKIN SA
    Increasing Complexity of Vaccine Development.
    J Infect Dis. 2015;212 Suppl 1:S12-6.
    PubMed     Text format     Abstract available


  69. VAN DER VRIES E, Ip DK, Cowling BJ, Zhang JD, et al
    Outcomes and Susceptibility to Neuraminidase Inhibitors in Individuals Infected with Different Influenza B Lineages: the Influenza Resistance Information Study.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  70. FONVILLE JM, Fraaij PL, de Mutsert G, Wilks SH, et al
    Antigenic maps of influenza A/H3N2 virus produced with human antisera obtained after primary infection.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    June 2015
  71. URAKI R, Piao Z, Akeda Y, Iwatsuki-Horimoto K, et al
    A bivalent vaccine based on a PB2-knockout influenza virus protects mice from secondary pneumococcal pneumonia.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  72. NUNES MC, Cutland CL, Dighero B, Bate J, et al
    Kinetics of hemagglutination-inhibition antibodies following maternal influenza vaccination in HIV-infected and HIV-uninfected women-infant dyads.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  73. LEENTJENS J, Kox M, Stokman R, Gerretsen J, et al
    BCG-vaccination enhances immunogenicity of subsequent influenza vaccination in healthy volunteers: a randomized placebo-controlled pilot study.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  74. INAGAKI K, Song MS, Crumpton JC, DeBeauchamp J, et al
    Determination of Influenza Virus Infectivity and Correlation to Diagnostic Assays in Ferret Model.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  75. CAO W, Mishina M, Ranjan P, De La Cruz JA, et al
    A newly emerged swine origin A(H3N2)v influenza virus dampens host antiviral immunity but induces potent inflammasome activation.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    May 2015
  76. WONG G, Qiu X, Ebihara H, Feldmann H, et al
    Characterization of a Bivalent Vaccine Capable of Inducing Protection Against Both Ebola and Cross-clade H5N1 Influenza in Mice.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  77. PETRIE JG, Ohmit SE, Johnson E, Truscon R, et al
    Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  78. HASEGAWA K, Jartti T, Mansbach JM, Laham FR, et al
    Respiratory syncytial virus genomic load and disease severity among children hospitalized with bronchiolitis: multicenter cohort studies in the United States and Finland.
    J Infect Dis. 2015;211:1550-9.
    PubMed     Text format     Abstract available


  79. GREENBAUM A, Quinn C, Bailer J, Su S, et al
    Investigation of an outbreak of variant influenza A (H3N2) virus associated with an agricultural fair - Ohio, August 2012.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  80. LAURIE KL, Guarnaccia TA, Carolan LA, Yan AW, et al
    The time-interval between infections and viral hierarchies are determinants of viral interference following influenza virus infection in a ferret model.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  81. SCHULTZ-CHERRY S
    Viral Interference: The Case of Influenza Viruses.
    J Infect Dis. 2015.
    PubMed     Text format    


  82. TAMURA D, DeBiasi RL, Okomo-Adhiambo M, Mishin VP, et al
    Emergence of multidrug resistant influenza A(H1N1)pdm09 virus variants in an immunocompromised child treated with oseltamivir and zanamivir.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  83. MILLER MR, Peters TR, Suerken CK, Snively BM, et al
    Predictors of Influenza Diagnosis among Patients with Laboratory-Confirmed Influenza.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    April 2015
  84. CHENG Z, Zhou J, To KK, Chu H, et al
    The identification of TMPRSS2 as the susceptible gene for severe illness of 2009 pandemic A(H1N1) influenza and infection of A(H7N9) influenza.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  85. TSANG TK, Cowling BJ, Fang VJ, Chan KH, et al
    Influenza A virus shedding and infectivity in households.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  86. ECKARD L, Webby R
    Neuraminidase: another piece of the influenza vaccine puzzle.
    J Infect Dis. 2015.
    PubMed     Text format    


  87. MONTO AS, Petrie JG, Cross RT, Johnson E, et al
    Antibody to the influenza neuraminidase: an independent correlate of protection.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  88. HALLILEY JL, Khurana S, Krammer F, Fitzgerald T, et al
    High Affinity H7 Head and Stalk Domain-Specific Antibody Responses to an Inactivated Influenza H7N7 Vaccine after Priming with Live Attenuated Influenza Vaccine.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    March 2015
  89. NAJARRO K, Nguyen H, Chen G, Xu M, et al
    Telomere Length as an Indicator of the Robustness of B- and T-cell Response to Influenza in Older Adults.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  90. ARRIOLA CS, Anderson EJ, Baumbach J, Bennett N, et al
    Does influenza vaccination modify influenza disease severity? Data on older adults hospitalized with influenza during the 2012-13 season in the United States.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  91. TERAJIMA M, Co MD, Cruz J, Ennis FA, et al
    High Antibody-Dependent Cellular Cytotoxicity Antibody Titers to H5N1 and H7N9 Avian Influenza A Viruses in Healthy US Adults and Older Children.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  92. SKOWRONSKI DM, Chambers C, Sabaiduc S, De Serres G, et al
    Integrated sentinel surveillance linking genetic, antigenic and epidemiologic monitoring of influenza vaccine-virus relatedness and effectiveness, 2013-14 season.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  93. SIMOES EA, DeVincenzo JP, Boeckh M, Bont L, et al
    Challenges and opportunities in developing respiratory syncytial virus therapeutics.
    J Infect Dis. 2015;211 Suppl 1:S1-S20.
    PubMed     Text format     Abstract available


  94. KAY AW, Bayless NL, Fukuyama J, Aziz N, et al
    Pregnancy Does Not Attenuate the Antibody or Plasmablast Response to Inactivated Influenza Vaccine.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    February 2015
  95. JUDD MC, Emukule GO, Njuguna H, McMorrow ML, et al
    The Role of HIV in the Household Introduction and Transmission of Influenza in an Urban Slum, Nairobi, Kenya, 2008-2011.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  96. SCHUIND A, Segall N, Drame M, Innis BL, et al
    Immunogenicity and safety of an EB66 cell-culture-derived A/Indonesia/5/2005 (H5N1)-AS03-adjuvanted influenza vaccine: Phase-I randomized trial.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  97. MCMORROW ML, Wemakoy EO, Tshilobo JK, Emukule GO, et al
    Severe acute respiratory illness deaths in Sub-Saharan Africa and the role of influenza: a case-series from 8 countries.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  98. KHAN SU, Anderson BD, Heil GL, Liang S, et al
    A Systematic Review and Meta-Analysis of the Seroprevalence of Influenza A (H9N2) Virus Infection Among Humans.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  99. WINOKUR PL, Patel SM, Brady R, Chen WH, et al
    Safety and Immunogenicity of a Single Low or High Dose of Clade 2 H5N1 Inactivated Influenza Vaccine in Adults Previously Primed with Clade 1 H5N1 Vaccine.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  100. AVADHANULA V, Chemaly RF, Shah DP, Ghantoji SS, et al
    Infection with novel respiratory syncytial virus genotype Ontario (ON1) in adult hematopoietic cell transplant recipients, Texas, 2011-2013.
    J Infect Dis. 2015;211:582-9.
    PubMed     Text format     Abstract available


  101. METZGER DW, Furuya Y, Salmon SL, Roberts S, et al
    Limited Efficacy of Anti-Bacterial Vaccination Against Secondary Serotype 3 Pneumococcal Pneumonia Following Influenza Infection.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  102. KEITEL WA, Jackson LA, Edupuganti S, Winokur PL, et al
    Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A/H3N2 Variant (H3N2v) Vaccine in Healthy Persons>/=18 Years Old.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  103. CHEUNG DH, Tsang TK, Fang VJ, Xu J, et al
    Association of oseltamivir treatment with virus shedding, illness, and household transmission of influenza viruses.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    January 2015
  104. SCHUSTER JE, Cox RG, Hastings AK, Boyd KL, et al
    A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus.
    J Infect Dis. 2015;211:216-25.
    PubMed     Text format     Abstract available


  105. EGLI A, Humar A, Widmer LA, Lisboa LF, et al
    Effect of Immunosuppression on Th2 and B-cell Responses to Influenza Vaccination.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  106. VAN DE SANDT CE, Hillaire ML, Geelhoed-Mieras MM, Osterhaus AD, et al
    Human influenza A virus-specific CD8+ T cell response is long-lived.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  107. GEORGE VK, Pallikkuth S, Parmigiani A, Alcaide M, et al
    HIV infection worsens Age-Associated Defects in Antibody Responses to Influenza Vaccine.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  108. MAIR-JENKINS J, Saavedra-Campos M, Baillie JK, Cleary P, et al
    The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.
    J Infect Dis. 2015;211:80-90.
    PubMed     Text format     Abstract available


    December 2014
  109. JOHNSON C, Hohenboken M, Poling T, Jaehnig P, et al
    Safety and Immunogenicity of Cell Culture-Derived A/H3N2 Variant Influenza Vaccines: A Phase I Randomized, Observer Blind, Dose-Ranging Study.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


  110. LINDLEY MC, Bridges CB
    Multifaceted Strategies Needed for Influenza Prevention in Long-term Care.
    J Infect Dis. 2014.
    PubMed     Text format    


  111. NACE DA, Lin CJ, Ross TM, Saracco S, et al
    Randomized, Controlled Trial of High-Dose Influenza Vaccine Among Frail Residents of Long-Term Care Facilities.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


  112. MINA MJ, Klugman KP, Rosch JW, McCullers JA, et al
    Live-attenuated influenza virus increases pneumococcal translocation and persistence within the middle ear.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


  113. RICHARDS KA, Nayak J, Chaves FA, DiPiazza A, et al
    Seasonal influenza can poise hosts for CD4 T cell immunity to H7N9 avian influenza.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


    November 2014
  114. MOHN KG, Bredholt G, Brokstad KA, Pathirana RD, et al
    The Longevity of B & T cell responses after live attenuated influenza vaccination in children.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


  115. OHMIT SE, Petrie JG, Malosh RE, Fry AM, et al
    Influenza Vaccine Effectiveness in Households with Children during the 2012-2013 Season: Assessments of Prior Vaccination and Serologic Susceptibility.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


  116. NEUZIL KM
    How can we solve the enigma of influenza vaccine-induced protection?
    J Infect Dis. 2014.
    PubMed     Text format    


  117. MCLEAN HQ, Thompson MG, Sundaram ME, Kieke BA, et al
    Influenza Vaccine Effectiveness in the United States During 2012-13: Variable Protection by Age and Virus Type.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


  118. RODRIGO C, Leonardi-Bee J, Nguyen-Van-Tam JS, Lim WS, et al
    Effect of corticosteroid therapy on influenza-related mortality: a systematic review and meta-analysis.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


  119. NAYAK JL, Richards KA, Yang H, Treanor JJ, et al
    The effect of influenza A(H5N1) pre-pandemic priming on CD4 T-cell responses.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


  120. MOHANTY S, Joshi SR, Ueda I, Wilson J, et al
    Prolonged Pro-Inflammatory Cytokine Production in Monocytes Following Influenza Vaccination is Modulated by IL-10 in Older Adults.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


    May 2014
  121. CALLAHAN ST, Wolff M, Hill HR, Edwards KM, et al
    Impact of Body Mass Index on Immunogenicity of Pandemic H1N1 Vaccine in Children and Adults.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: